
    
      This study is an exploratory study designed as a group sequential single and multiple
      escalating dose, double-blind within cohort, randomized, placebo controlled study to
      investigate the safety and tolerability as well as the pharmacokinetics and pharmacodynamics
      of SNX-001 given as oral doses in aged volunteers.
    
  